BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15952507)

  • 1. [Optimising patient isolation due to methicillin-resistant Staphylococcus aureus].
    Keeman JN
    Ned Tijdschr Geneeskd; 2005 May; 149(22):1243. PubMed ID: 15952507
    [No Abstract]   [Full Text] [Related]  

  • 2. [Optimising patient isolation due to methicllin-resistant Staphylococcus aureus].
    Kluytmans JA; van den Broek PJ
    Ned Tijdschr Geneeskd; 2005 Apr; 149(15):794-6. PubMed ID: 15850268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy.
    J Hosp Infect; 1986 Mar; 7(2):193-201. PubMed ID: 2871084
    [No Abstract]   [Full Text] [Related]  

  • 4. [The current MRSA policy in the Netherlands is doing more harm than good].
    van Beijnum J; Woerdeman PA; Tulleken CA
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1885. PubMed ID: 16970012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus: misinterpretation and misrepresentation of active detection and isolation.
    Farr BM; Jarvis WR
    Clin Infect Dis; 2008 Nov; 47(9):1238-9; author reply 1239-40. PubMed ID: 18831705
    [No Abstract]   [Full Text] [Related]  

  • 6. A modest proposal.
    Van Arsdall JA
    J Ky Med Assoc; 2006 Sep; 104(9):425-7. PubMed ID: 17100121
    [No Abstract]   [Full Text] [Related]  

  • 7. Preemptive isolation to prevent methicillin-resistant Staphylococcus aureus cross-transmission in diabetic foot.
    Lecornet E; Robert J; Jacqueminet S; Van Georges H; Jeanne S; Bouilloud F; Veyrie C; Jarlier V; Grimaldi A; Hartemann-Heurtier A
    Diabetes Care; 2007 Sep; 30(9):2341-2. PubMed ID: 17586742
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical epidemiology of an outbreak of nosocomial infections by Staphylococcus aureus resistant to methicillin and aminoglucosides: efficacy of the measures of control].
    Parras F; Coello R
    Med Clin (Barc); 1993 Sep; 101(9):359. PubMed ID: 8412405
    [No Abstract]   [Full Text] [Related]  

  • 9. Methicillin resistant Staphylococcus aureus: where are we now?
    Allen DM
    Singapore Med J; 1991 Feb; 32(1):17-9. PubMed ID: 2017696
    [No Abstract]   [Full Text] [Related]  

  • 10. High colonization pressure might compromise the efficiency of routine methicillin-resistant Staphylococcus aureus screening.
    Pavlov I
    Clin Infect Dis; 2007 Mar; 44(5):766; author reply 766-7. PubMed ID: 17278082
    [No Abstract]   [Full Text] [Related]  

  • 11. A flexible approach to methicillin-resistant Staphylococcus aureus (MRSA).
    Nolan JL
    Nurs Times; 2001 May 31-Jun 6; 97(22):60-2. PubMed ID: 11954438
    [No Abstract]   [Full Text] [Related]  

  • 12. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of screening and isolation for control of methicillin-resistant Staphylococcus aureus.
    Verbrugh HA
    Clin Infect Dis; 2005 Jul; 41(2):268-9; author reply 270-1. PubMed ID: 15983928
    [No Abstract]   [Full Text] [Related]  

  • 14. An analysis of patient characteristics for methicillin-resistant Staphylococcus aureus colonization and infection in a hospital population.
    Archbald CD; Powers JS; Burger MC; Dixon R; Hall A
    J Tenn Med Assoc; 1993 Mar; 86(3):102-4. PubMed ID: 8445905
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of compliance with preventive barrier precautions to control meticillin-resistant Staphylococcus aureus cross-transmission in four non-intensive acute-care wards of a French teaching hospital.
    Eveillard M; Grandin S; Zihoune N; Benlolo JA; Branger C; Dreyfuss D; de Lassence A
    J Hosp Infect; 2007 Jan; 65(1):81-3. PubMed ID: 17145097
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.
    Humphreys H; Smyth EG
    J Hosp Infect; 2005 Mar; 59(3):259-61; author reply 263-6. PubMed ID: 15694985
    [No Abstract]   [Full Text] [Related]  

  • 17. A useful clinical approach to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections.
    Cunha BA
    J Hosp Infect; 2008 Mar; 68(3):271-3. PubMed ID: 18289722
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the efficacy of control measures in the management of infections caused by methicillin-resistant Staphylococcus aureus].
    Pujol Rojo M; Ariza Cardenal J
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():74-9. PubMed ID: 9441327
    [No Abstract]   [Full Text] [Related]  

  • 19. Cultures, bundles, and other options for MRSA control.
    ECRI Insitute
    Healthc Hazard Manage Monit; 2007 Jul; 20(11):1-10. PubMed ID: 17619466
    [No Abstract]   [Full Text] [Related]  

  • 20. Two studies feed the debate on active surveillance for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci carriage: to screen or not to screen?
    Talbot TR
    J Infect Dis; 2007 Feb; 195(3):314-7. PubMed ID: 17205467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.